CynosBio, Inc.
PrivateLast Round
Series C
Jul 22, 2024
Total Funding Raised
$15.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CynosBio, Inc. operates in Energy & Sustainability and is based in Tokyo. Its latest recorded funding round was a Series C round in July 2024.
CynosBio, Inc. is a biotechnology company that develops, manufactures, and markets regenerative medicine products for ophthalmic and orthopedic conditions.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CynosBio, Inc. Comparables
Compare CynosBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bacchus Bio innovation Co., Ltd. | 83% | |
| Lygos | 82% | |
| Conagen | 79% |
For institutional investors. Book with your work email.
CynosBio, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CynosBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 七十七キャピタル株式会社 | Series C |
| Sumitomo Mitsui Trust Bank | Series C |
| Fiducia Inc. | Series C |
| 日本ベンチャーキャピタル株式会社 | Series C |
| CEJ Capital | Series C |
| QB II Investment Limited Partnership | Series C |
| Mitsubishi UFJ Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 56% MoM.
- Jul 11, 2026
Grew 80% QoQ from 5 to 9 employees.
For institutional investors. Book with your work email.
CynosBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CynosBio, Inc.'s valuation, stock price, and market status.
Is CynosBio, Inc. a public or private company?
CynosBio, Inc. is a private company.
What is the current stock price of CynosBio, Inc.?
CynosBio, Inc. is a private company, so its shares have no public market price. Caplight tracks CynosBio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CynosBio, Inc. worth (valuation)?
Valuation information for CynosBio, Inc. is not publicly available.
Can I buy CynosBio, Inc. stock?
CynosBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CynosBio, Inc.'s last funding round?
CynosBio, Inc.'s most recent funding round was Series C on July 22, 2024.
Who are the main investors in CynosBio, Inc.?
Key investors in CynosBio, Inc. include CEJ Capital, Axil Capital.
Will CynosBio, Inc. IPO soon?
No public IPO plans have been announced for CynosBio, Inc..
How can I track CynosBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in CynosBio, Inc.'s shares on secondary markets.